文献速递垂体与肾上腺疾病

肢端肥大症患者口服葡萄糖后GH反常反应的临床特征

Clinical Characteristics of Acromegalic Patients With Paradoxical GH Response to Oral Glucose Load.
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

本研究回顾性分析63例肢端肥大症患者,其中19例为口服葡萄糖后GH反常反应者(OG反应者),44例为非反应者。结果显示OG反应者术前IGF-1 SD评分更高、糖代谢指标更差、生长抑素类似物和多巴胺激动剂试验中GH下降更显著、T2加权MRI低信号垂体瘤比例更高,术后这些差异消失。

要点

  • OG反应者术前IGF-1 SD评分显著高于非反应者。
  • OG反应者糖代谢指标(120分钟血糖、免疫反应性胰岛素、HbA1c)更差。
  • OG反应者药物试验中GH下降更显著且T2低信号瘤比例更高。

核心结论

  • 口服葡萄糖后GH反常反应反映了肢端肥大症的临床特征,尤其是IGF-1水平、糖代谢和药物疗效。
  • 除GH谷值外,OG负荷后GH反常反应可能有助于评估肢端肥大症的临床特征。

研究设计与样本

  • 回顾性研究,纳入2006年1月至2017年1月大阪大学医院收治的63例肢端肥大症患者。
  • 19例分类为OG反应者,44例为非反应者,比较两组临床特征。

主要发现

  • 术前OG反应者IGF-1 SD评分显著高于非反应者(P < 0.05),两组基础GH水平无差异(P = 0.46)。
  • OG后120分钟血糖、免疫反应性胰岛素和HbA1c在OG反应者中显著更高(分别为P < 0.01、P < 0.05、P < 0.05)。
  • 奥曲肽或溴隐亭试验中GH下降在OG反应者中更显著(分别为P < 0.05、P < 0.05)。
  • T2加权MRI低信号垂体瘤比例在OG反应者中显著更高(P < 0.05)。
  • 术后两组间IGF-1和糖代谢参数的差异消失。

临床怎么用

  • 对肢端肥大症患者行口服葡萄糖负荷试验时,除GH谷值外应关注GH反常反应。
  • OG反应者可能提示更高的IGF-1水平、更差的糖代谢及更好的药物反应性。

局限性

  • 回顾性研究,样本量较小(63例),来自单中心。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: A paradoxical GH response to oral glucose (OG) is often found in acromegaly. However, the clinical characteristics of patients with acromegaly and a paradoxical GH response to OG (OG responders) remain unclear. OBJECTIVE: The aim of the present study was to define the clinical characteristics of OG responders with acromegaly. DESIGN: Retrospective study. SETTING: Hospitalized care at Osaka University Hospital. PATIENTS AND METHODS: Of 63 patients with acromegaly admitted to our hospital from January 2006 to January 2017, 19 were classified as OG responders and 44 as nonresponders. The clinical characteristics of these groups were compared. RESULTS: Before surgery, OG responders had substantially greater IGF-1 SD scores than nonresponders (P < 0.05), although no difference was found in basal GH levels between the two groups (P = 0.46). Regarding glucose metabolism, 120-minute plasma glucose and immunoreactive insulin after OG administration and hemoglobin A1c were significantly greater in OG responders than in nonresponders (P < 0.01, P < 0.05, P < 0.05, respectively). GH levels during octreotide or bromocriptine testing were decreased more significantly in OG responders than in nonresponders (P < 0.05, P < 0.05, respectively). The proportion of pituitary tumors with hypointensity on T2-weighted MRI was significantly greater in OG responders than in nonresponders (P < 0.05). The difference in IGF-1 and parameters of glucose metabolism described disappeared between the two groups after surgery. CONCLUSIONS: The paradoxical GH response reflected the clinical characteristics, especially IGF-I level, glucose metabolism, and drug efficacy in acromegaly. A paradoxical GH response, in addition to the nadir GH levels, to OG load is potentially useful for evaluation of the clinical characteristics of acromegaly.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Mukai K, Otsuki M, Tamada D, et al. Clinical Characteristics of Acromegalic Patients With Paradoxical GH Response to Oral Glucose Load. J Clin Endocrinol Metab. 2019. PMID: 30476255. doi:10.1210/jc.2018-00975

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。